Schedule 13D ownership disclosure
ADURO BIOTECH, INC.
Security class unavailable · CUSIP: 00739L101
Event date: 2019-03-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,305,532
- Percent of class
- 11.6700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-016796
- Form type
- SC 13D
- Filer
- CHINOOK THERAPEUTICS, INC.
- CIK
- CIK 1435049
- Filed
- Mar 22, 2019
- Reporting period
- Mar 20, 2019
- Description
- Schedule 13D beneficial ownership